Parallax Volatility Advisers, L.P. - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 79 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$809,000
-5.3%
194,990
-4.6%
0.00%0.0%
Q1 2019$854,000
+6000.0%
204,293
+4239.3%
0.00%
Q4 2018$14,000
-98.2%
4,708
-95.0%
0.00%
-100.0%
Q4 2017$772,00094,6000.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,340,588$1,354,0000.34%
BOOTHBAY FUND MANAGEMENT, LLC 78,662$79,0000.02%
Orbimed Advisors 567,600$573,0000.01%
Acrospire Investment Management LLC 14,323$14,0000.01%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 10,000$10,0000.00%
Virtu KCG Holdings LLC 49,847$50,0000.00%
NEXT Financial Group, Inc 2,670$3,000,0000.00%
Squarepoint Ops LLC 13,000$13,0000.00%
FRANKLIN RESOURCES INC 2,182,185$2,204,0000.00%
A.R.T. Advisors, LLC 16,830$16,0000.00%
View complete list of MARINUS PHARMACEUTICALS INC shareholders